ANIKA THERAPEUTICS INC (ANIK) Stock News

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

BEDFORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

What's Next: Anika Therapeutics's Earnings Preview

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis (“OA”) Pain Management...

Microsoft To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Thursday

Mentions: ADBE INTC MRCY MSFT ...

ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Anika Therapeutics (NASDAQ:ANIK) just reported results for the second quarter o...

Anika Reports Fourth Quarter and Full Year 2024 Financial Results

Full Year 2024 results in line with guidance with Commercial Channel revenue up 17% Strong International OA Pain Management and greater than 40%...

Anika Completes Divestiture of Parcus Medical

Execution of Previously Announced Plan Sharpens Focus on Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio

Anika Completes Divestiture of Parcus Medical

Execution of Previously Announced Plan Sharpens Focus on Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio...

Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025

Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025

BEDFORD, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference

Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference

BEDFORD, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

BEDFORD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

Anika To Participate in December 2024 Investor Conferences

Anika To Participate in December 2024 Investor Conferences

BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

Anika Reports Third Quarter 2024 Financial Results

Updating 2024 fiscal year guidance to reflect announced changes to business strategy, including the sale of Arthrosurface and planned divestiture of Parcus...

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

Company to Focus on Profitable Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio, Streamline Operations and Enhance Growth Profile

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

Company to Focus on Profitable Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio, Streamline Operations and...

Anika Announces Third Quarter 2024 Results Conference Call Date

Anika Announces Third Quarter 2024 Results Conference Call Date

BEDFORD, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024

ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Anika Reports Second Quarter 2024 Financial Results

Expanded Regenerative Solutions portfolio with full market release of the Integrity™ Implant System, a hyaluronic acid (HA)-based scaffold for rotator cuff...